Search by Drug Name or NDC
NDC 51672-2117-04 Feverall 650 mg/1 Details
Feverall 650 mg/1
Feverall is a RECTAL SUPPOSITORY in the HUMAN OTC DRUG category. It is labeled and distributed by Taro Pharmaceuticals U.S.A. Inc.. The primary component is ACETAMINOPHEN.
MedlinePlus Drug Summary
Acetaminophen rectal is used to relieve mild to moderate pain from headaches or muscle aches and to reduce a fever. Acetaminophen is in a class of medications called analgesics (pain relievers) and antipyretics (fever reducers). It works by changing the way the body senses pain and by cooling the body.
Related Packages: 51672-2117-04Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Acetaminophen Rectal
Product Information
NDC | 51672-2117 |
---|---|
Product ID | 51672-2117_c107ee4d-6fd8-4cd8-9f80-5d140801eaba |
Associated GPIs | 64200010005220 |
GCN Sequence Number | 004478 |
GCN Sequence Number Description | acetaminophen SUPP.RECT 650 MG RECTAL |
HIC3 | H3E |
HIC3 Description | ANALGESIC/ANTIPYRETICS,NON-SALICYLATE |
GCN | 16907 |
HICL Sequence Number | 001866 |
HICL Sequence Number Description | ACETAMINOPHEN |
Brand/Generic | Brand |
Proprietary Name | Feverall |
Proprietary Name Suffix | Adults |
Non-Proprietary Name | Acetaminophen |
Product Type | HUMAN OTC DRUG |
Dosage Form | SUPPOSITORY |
Route | RECTAL |
Active Ingredient Strength | 650 |
Active Ingredient Units | mg/1 |
Substance Name | ACETAMINOPHEN |
Labeler Name | Taro Pharmaceuticals U.S.A. Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA018337 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 51672-2117-04 (51672211704)
NDC Package Code | 51672-2117-4 |
---|---|
Billing NDC | 51672211704 |
Package | 50 BLISTER PACK in 1 CARTON (51672-2117-4) / 1 SUPPOSITORY in 1 BLISTER PACK (51672-2117-0) |
Marketing Start Date | 2013-12-12 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 7afa4b78-5e14-4723-a87b-01f664b0c0e9 Details
Warnings
Liver warning
This product contains acetaminophen. Severe liver damage may occur if
- an adult or child 12 years and older takes more than 6 doses in 24 hours, which is the maximum daily amount
- taken with other drugs containing acetaminophen
- an adult takes 3 or more alcoholic drinks every day while using this product
Allergy alert: acetaminophen may cause severe skin reactions. Symptoms may include:
- skin reddening
- blisters
- rash
Do not use
- in children under 12 years.
- if you are allergic to acetaminophen.
- with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
Directions
Other information
Inactive ingredients
PRINCIPAL DISPLAY PANEL - 50 Suppository Carton
INGREDIENTS AND APPEARANCE
FEVERALL
ADULTS
acetaminophen suppository |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Taro Pharmaceuticals U.S.A. Inc. (145186370) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
G&W NC Laboratories, Inc. | 079419931 | MANUFACTURE(51672-2117) |
Revised: 5/2016
Document Id: c107ee4d-6fd8-4cd8-9f80-5d140801eaba
Set id: 7afa4b78-5e14-4723-a87b-01f664b0c0e9
Version: 6
Effective Time: 20160519